Agomelatine vs placebo
Number of participants experiencing at least one severe adverse event · adults with a history of SAD
It is very uncertain whether agomelatine changes number of persons with at least one severe adverse event within a year compared with placebo (very low certainty).
1 finding from 1 review
- Melatonin and agomelatine for preventing seasonal affective disorder 2019 · Cochrane Headline outcomes onlyRR 0.76 [0.17, 3.3]1 study · 225 participantsVery low